Clarus Therapeutics Holdings, Inc. Aktie
Aktien
A3C2HG
US18271L1070
CRXT
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Robert Dudley
FOU | Founder | 69 | 01.01.04 |
Jay Newmark
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kara Stancell
IRC | Investor Relations Contact | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Robert Dudley
FOU | Founder | 69 | 01.01.04 |
% 1. Jan. | Kap. | |
---|---|---|
+27.97% | 672 Mrd. | |
+23.62% | 550 Mrd. | |
-7.02% | 351 Mrd. | |
+14.85% | 317 Mrd. | |
+6.25% | 292 Mrd. | |
+2.21% | 211 Mrd. | |
-0.35% | 203 Mrd. | |
-9.98% | 194 Mrd. | |
-11.81% | 144 Mrd. |